Muscle Stimulator Market

In the year 2020, the global muscle stimulator market reached a valuation of $122,460.00 thousand, and it is anticipated to achieve $183,887.64 thousand by the year 2030, marking a compound annual growth rate (CAGR) of 4.08% from 2023 to 2030. Electrical muscle stimulation (EMS) involves triggering muscle contractions using electric impulses. EMS has gained substantial traction in recent years, serving as a strength training tool for both healthy individuals and athletes. Moreover, it finds applications in rehabilitation and prevention for individuals who are partially or fully immobilized, as well as a diagnostic tool for assessing neural and muscular function in vivo. Athletes also use it for post-exercise recovery.

The expansion of the global muscle stimulator market is fueled by several factors, including the growing popularity of sports, a rising demand for fitness products, an increasing geriatric population, and a surge in musculoskeletal and neuromuscular disorders. Additionally, heightened awareness about electrical muscle stimulation therapies and a preference among physiotherapists for such methods contribute to the market's growth. Nonetheless, challenges such as the absence of usage guidelines, safety concerns, regulatory uncertainties in the U.S., and the availability of alternative therapies pose limitations. Conversely, the development of wireless portable muscle stimulators presents promising opportunities in the forecast period.

Impact Of Covid-19 On Muscle Stimulator Market (Pre And Post Analysis)

The COVID-19 pandemic, caused by the SARS-CoV-2 virus, was identified in late December in China's Hubei province. The pandemic disrupted supply chains due to trade restrictions on pharmaceutical ingredients and products worldwide. Additionally, COVID-19 shares flu-like symptoms, including fever, cough, and respiratory difficulties, leading to disruptions in clinical trials and drug supply.

The pandemic notably impacted the muscle stimulator market, with a reduction in many types of outpatient tests and treatments, particularly surgical treatments. Several market players, such as Neurometrix Inc., experienced a drop in revenue in their stimulator platform due to COVID-19. For instance, Neurometrix Inc. reported a 20% decrease in net sales in the fiscal year 2019-2020, primarily due to the cancellation of elective procedures and treatments in the U.S. and postponements in elective procedures outside the U.S. The pandemic also led to temporary halts in commercial investments for some companies. However, the situation is expected to evolve post-COVID-19 in the years to come.

The muscle stimulator market is segmented by product type, modality, application, end-user, and region. Product types include neuromuscular electrical stimulation, functional electrical stimulation, interferential, burst mode alternating current, microcurrent electrical neuromuscular stimulator, and others. Modalities encompass portable and handheld, as well as tabletop devices. Applications involve pain management, muscle rehabilitation, muscle atrophy, muscle toning and strengthening, muscle spasticity and spasms, among others. End-users include physical therapy and rehabilitation clinics, hospitals, ambulatory surgery centers, and home care. Geographically, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Product type Segment Review

In terms of product types, the muscle stimulator market is categorized into neuromuscular electrical stimulation, functional electrical stimulation, interferential, burst mode alternating current, microcurrent electrical neuromuscular stimulator, and others. In 2020, the neuromuscular electrical stimulation segment led in revenue generation. This can be attributed to the increasing prevalence of arthritis and a rise in sports-related injuries. Furthermore, the neuromuscular electrical stimulation segment is poised to exhibit the highest growth rate, primarily driven by the growing demand for muscle stimulation therapy in developing nations.

By Product Type

Modality Segment Review

Among modalities, the portable and handheld segment held the major share of revenue in 2020 and is expected to maintain this trend in the forecast period. Additionally, this segment is anticipated to register the fastest growth rate due to key market players introducing innovative portable muscle stimulator devices to stay competitive.

Application Segment Review

In terms of applications, the muscle rehabilitation segment was the leading revenue contributor in 2020 and is expected to continue its dominance throughout the forecast period. Moreover, the pain management segment is projected to demonstrate the fastest growth rate. This is attributed to the increasing prevalence of chronic and acute pain conditions and the growing need for effective pain management therapies, particularly among cancer patients.

By Application

End-user Segment Review

Within the end-user category, the physical therapy and rehabilitation clinics segment accounted for the highest revenue in 2020 and is anticipated to maintain this position in the forecast period. This segment is also expected to exhibit the fastest growth rate due to the increasing preference of physiotherapists for stimulators over manual techniques.

Region Segment Review

In terms of regions, North America dominated the revenue share in 2020 and is expected to uphold its leadership from 2023 to 2030. This is attributed to the presence of a sizable patient population, a strong presence of key market players, well-developed healthcare infrastructure, and favorable reimbursement policies within the healthcare system. However, Asia-Pacific is poised to experience the swiftest compound annual growth rate (CAGR). This growth can be attributed to the rising incidence of musculoskeletal disorders and an increase in awareness regarding electrical muscle stimulation therapy in the region.

Key benefits for stakeholders

• This report offers a detailed quantitative examination of the prevailing muscle stimulator market trends and forecasts spanning from 2020 to 2030. This aids in the identification of existing market opportunities.
• It includes a thorough market analysis across different regions, providing valuable insights into current trends and enabling stakeholders to devise region-specific strategies.
• A comprehensive assessment of the factors propelling and impeding the global muscle stimulator market's growth is provided.
• The projections in this report are based on an analysis of current trends and the future potential of the muscle stimulator market, specifically in terms of its value, for the period spanning from 2020 to 2030.
• Through extensive regional analysis, this report furnishes insights that will assist companies in strategically planning their business initiatives.
• The report profiles key market players and conducts a comprehensive analysis of their strategies, facilitating a deeper understanding of the competitive landscape within the muscle stimulator market.

Muscle Stimulator Market Report Highlights

By Product Type

• Neuromuscular Electrical Stimulation
• Functional Electrical Stimulation
• Interferential
• Burst Mode Alternating Current
• Microcurrent Electrical Neuromuscular Stimulation
• Others

By Modality

• Portable & Handheld
• Table Top

By Application

• Pain Management
• Muscle Rehabilitation
• Muscle Atrophy
• Muscle Toning & Strengthening
• Muscle Spasticity & Spasms
• Others

By End User

• Physical Therapy and Rehabilitation Clinics
• Hospitals
• Ambulatory Surgery Centers
• Home Care

By Region

• North America  (U.S., Canada, Mexico)
• Europe  (Germany, France, UK, Italy, Spain, Rest of Europe)
• Asia Pacific  (Japan, China, Australia, India, South Korea, Rest of Asia Pacific)
• LAMEA  (Brazil, Saudi Arabia, South Africa, Rest of LAMEA)

Key Market Players

• AxioBionics LLC
• Beurer GmbH
• BioMedical Life Systems, Inc.
• Colfax Corporation (DJO Global Inc.)
• EMS Physio Ltd.
• Liberate Medical
• OG Wellness Technologies Co., Ltd.
• RS Medical
• Zimmer MedizinSysteme GmbH
• Zynex Medical